+高级检索
首页 > 优先出版
PDF HTML阅读 XML下载 导出引用 引用提醒
地榆通过影响PPARG和SLC7A11/GPX4表达减轻溃疡性结肠炎小鼠损伤
作者:
作者单位:

河北医科大学 药学院

基金项目:

国家自然科学基金资助项目(82003913)；河北省高等学校科学技术研究项目(BJK2024082)；河北省自然科学基金资助项目(H2020206010)；河北省中医药管理局项目(2021120)


Sanguisorbae Radix alleviates damage in Ulcerative Colitis Mice Based on PPARG and SCL7A11/GPX4
Author:
Affiliation:

1.College of Pharmacy,Hebei Medical University,Shijiazhuang,050017;2.Hebei,China;3.College of Pharmacy,Hebei Medical University

Fund Project:

The National Natural Science Foundation of China (General Program, Key Program, Major Research Plan)

  • 摘要
    • | |
  • 访问统计
    • |
  • 参考文献 [40]
    • |
  • 相似文献
    • | | |
  • 文章评论
    摘要:

    目的：基于生物信息学探究地榆(Sanguisorbae Radix,SR)改善小鼠溃疡性结肠炎的机制。方法：利用R语言对高通量基因表达数据库(GEO)中GSE92415数据集进行溃疡性结肠炎(UC)差异表达基因筛选和加权基因共表达网络分析(WGCNA),并结合FerrDb数据库,获得UC相关铁死亡特征基因。对特征基因进行蛋白互作分析(PPI)和相关性分析,筛选UC铁死亡核心基因。构建葡聚糖硫酸钠(DSS)诱导的UC小鼠模型,并灌胃给予SR水提物9 d,记录疾病活动指数(DAI)和结肠长度,采用HE染色法观察结肠组织病理变化,酶联免疫吸附测定法(ELISA)检测小鼠结肠组织炎症因子肿瘤坏死因子(TNF)-α、白细胞介素-6(IL-6)和脂质过氧化因子丙二醛(MDA)、谷胱甘肽(GSH)水平,免疫荧光法检测结肠组织闭锁小带蛋白1(ZO-1)表达,蛋白免疫印迹法(Western blotting)检测结肠组织过氧化物酶体增殖物激活受体γ(PPARG)、溶质载体家族7成员11(SLC7A1)和谷胱甘肽过氧化酶4(GPX4)蛋白表达。结果：通过生物信息学筛选得到9个UC相关铁死亡特征基因,其中核心基因为PPARG。相关性分析发现PPARG与铁死亡高度相关。结合生物信息学筛选结果,探讨SR改善小鼠UC的机制,实验结果发现,SR可降低UC小鼠DAI值,缓解结肠缩短,改善肠道粘膜屏障功能,对TNF-α、IL-6、MDA、GSH水平有显著回调作用,并可提高结肠组织PPARG、SLC7A11和GPX4蛋白表达。结论：铁死亡与UC密切相关,SR可通过影响PPARG 和SCL7A11/GPX4蛋白,进而改善UC小鼠结肠上皮损伤和功能障碍,为UC治疗策略提供了思路与方向。

    Abstract:

    Objective: To investigate the mechanism of Sanguisorbae Radix (SR) in the treatment of Ulcerative Colitis (UC). Methods: The study analyzed GSE92415 from the Gene Expression Omnibus (GEO) database using differentially expressed genes analysis, weighted gene correlation network analysis (WGCNA) and FerrDb. Core genes were identified through protein-protein interaction (PPI) network and correlation analysis. The efficacy of SR in UC was evaluated in a dextran sodium sulphate (DSS)-induced colonic inflammatory mouse model by analyzing DAI, histopathology and colon length. ELISA was used to examine levels of inflammatory cytokines and lipid peroxidation. The expression levels of ZO-1 tight junction protein, PPARG, SLC7A11 and GPX4 protein were examined through Western blotting or immunofluorescence labeling. Results:S Nine differentially expressed genes associated with ferroptosis were screened and PPARG was identified as a key gene. The experimental animal results showed that SR significantly prevented colon shortening and ameliorated histological injuries of colons in DSS-treated mice. SR inhibited cytokine levels of IL-6 and TNF-α, improved the reduction of ZO-1 and levels of MDA and GSH in colon tissues of DSS mice. Meanwhile, it enhanced the activation of PPARG, SLC7A11 and GPX4, which reversed the therapeutic effect of DSS in mice with colitis. Conclusion: Iron death is closely related to UC. SR can inhibit iron death by regulating the PPARG and SCL7A11/GPX4 expression, thereby improving colon epithelial injury and dysfunction in UC mice. This provides ideas and direction for UC treatment strategies.

    参考文献
    [1] Kobayashi T, Siegmund B, Le Berre C, et al. Ulcerative colitis[J]. Nat Rev Dis Primers, 2020,6(1):74.
    [2] Ungaro R, Mehandru S, Allen P B, et al. Ulcerative colitis[J]. Lancet, 2017,389(10080):1756-1770.
    [3] Xu S, He Y, Lin L, et al. The emerging role of ferroptosis in intestinal disease[J]. Cell Death Dis, 2021,12(4):289.
    [4] Sandborn W J, Panes J, Sands B E, et al. Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme[J]. Aliment Pharmacol Ther, 2019,50(10):1068-1076.
    [5] Segal J P, Leblanc J F, Hart A L. Ulcerative colitis: an update[J]. Clin Med (Lond), 2021,21(2):135-139.
    [6] Feagan B G, Rutgeerts P, Sands B E, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis[J]. N Engl J Med, 2013,369(8):699-710.
    [7] Lamb C A, Kennedy N A, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults[J]. Gut, 2019,68(Suppl 3):s1-s106.
    [8] Sandborn W J, Panes J, Sands B E, et al. Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme[J]. Aliment Pharmacol Ther, 2019,50(10):1068-1076.
    [9] Dixon S J, Lemberg K M, Lamprecht M R, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012,149(5):1060-1072.
    [10] Xu S, He Y, Lin L, et al. The emerging role of ferroptosis in intestinal disease[J]. Cell Death Dis, 2021,12(4):289.
    [11] Xu M, Tao J, Yang Y, et al. Ferroptosis involves in intestinal epithelial cell death in ulcerative colitis[J]. Cell Death Dis, 2020,11(2):86.
    [12] Chen Y, Zhang P, Chen W, et al. Ferroptosis mediated DSS-induced ulcerative colitis associated with Nrf2/HO-1 signaling pathway[J]. Immunol Lett, 2020,225:9-15.
    [13] 王英英, 朱洁, 鲁兰, 等. 中药地榆的成分以及其药理作用研究进展[J]. 四川中医, 2022,40(08):216-223.Wang YY, Zhu J, Lu L, et al. Advances in the Study of Components and Pharmacological Effects of Traditional Chinese Medicine Sanguisorba officinalis L.[J]. J Sichuan Tradit Chin Med, 2022,40(08):216-223.
    [14] Zhang W, Sang S, Peng C, et al. Network Pharmacology and Transcriptomic Sequencing Analyses Reveal the Molecular Mechanism of Sanguisorba officinalis Against Colorectal Cancer[J]. Front Oncol, 2022,12:807718.
    [15] Zhang W, Peng C, Yan J, et al. Sanguisorba officinalis L. suppresses 5-fluorouracil-sensitive and-resistant colorectal cancer growth and metastasis via inhibition of the Wnt/beta-catenin pathway[J]. Phytomedicine, 2022,94:153844.
    [16] Yu T, Wu L, Zhang T, et al. Insights into Q-markers and molecular mechanism of Sanguisorba saponins in treating ulcerative colitis based on lipid metabolism regulation[J]. Phytomedicine, 2023,116:154870.
    [17] Long W, Liu S, Li X X, et al. Whole transcriptome sequencing and integrated network analysis elucidates the effects of 3,8-Di-O-methylellagic acid 2-O-glucoside derived from Sanguisorba offcinalis L., a novel differentiation inducer on erythroleukemia cells[J]. Pharmacol Res, 2021,166:105491.
    [18] Lachowicz S, Oszmianski J, Rapak A, et al. Profile and Content of Phenolic Compounds in Leaves, Flowers, Roots, and Stalks of Sanguisorba officinalis L. Determined with the LC-DAD-ESI-QTOF-MS/MS Analysis and Their In Vitro Antioxidant, Antidiabetic, Antiproliferative Potency[J]. Pharmaceuticals (Basel), 2020,13(8).
    [19] Zhu H, Chen G, Chen S, et al. Characterization of polyphenolic constituents from Sanguisorba officinalis L. and its antibacterial activity[J]. Eur Food Res Technol, 2019,245(7):1487-1498.
    [20] Song J, Zeng J, Zheng S, et al. Sanguisorba officinalis L. promotes diabetic wound healing in rats through inflammation response mediated by macrophage[J]. Phytother Res, 2023,37(9):4265-4281.
    [21] Li C, Gong L, Jiang Y, et al. Sanguisorba officinalis ethyl acetate extract attenuates ulcerative colitis through inhibiting PI3K-AKT/NF-kappaB/ STAT3 pathway uncovered by single-cell RNA sequencing[J]. Phytomedicine, 2023,120:155052.
    [22] Yu T, Wu L, Zhang T, et al. Insights into Q-markers and molecular mechanism of Sanguisorba saponins in treating ulcerative colitis based on lipid metabolism regulation[J]. Phytomedicine, 2023,116:154870.
    [23] Dignass A, Lindsay J O, Sturm A, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management[J]. J Crohns Colitis, 2012,6(10):991-1030.
    [24] Chen Y, Zhang P, Chen W, et al. Ferroptosis mediated DSS-induced ulcerative colitis associated with Nrf2/HO-1 signaling pathway[J]. Immunol Lett, 2020,225:9-15.
    [25] Wan Y, Yang L, Jiang S, et al. Excessive Apoptosis in Ulcerative Colitis: Crosstalk Between Apoptosis, ROS, ER Stress, and Intestinal Homeostasis[J]. Inflamm Bowel Dis, 2022,28(4):639-648.
    [26] Cui L, Guan X, Ding W, et al. Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota[J]. Int J Biol Macromol, 2021,166:1035-1045.
    [27] Xu M, Tao J, Yang Y, et al. Ferroptosis involves in intestinal epithelial cell death in ulcerative colitis[J]. Cell Death Dis, 2020,11(2):86.
    [28] Kobayashi Y, Ohfuji S, Kondo K, et al. Association between dietary iron and zinc intake and development of ulcerative colitis: A case-control study in Japan[J]. J Gastroenterol Hepatol, 2019,34(10):1703-1710.
    [29] Chen Y, Zhang P, Chen W, et al. Ferroptosis mediated DSS-induced ulcerative colitis associated with Nrf2/HO-1 signaling pathway[J]. Immunol Lett, 2020,225:9-15.
    [30] Vermeire S. Combination biologic therapy for ulcerative colitis[J]. Lancet Gastroenterol Hepatol, 2023,8(4):288-290.
    [31] Stockwell B R, Friedmann A J, Bayir H, et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease[J]. Cell, 2017,171(2):273-285.
    [32] Imai H, Matsuoka M, Kumagai T, et al. Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis[J]. Curr Top Microbiol Immunol, 2017,403:143-170.
    [33] Wang S, Liu W, Wang J, et al. Curculigoside inhibits ferroptosis in ulcerative colitis through the induction of GPX4[J]. Life Sci, 2020,259:118356.
    [34] Xu M, Tao J, Yang Y, et al. Ferroptosis involves in intestinal epithelial cell death in ulcerative colitis[J]. Cell Death Dis, 2020,11(2):86.
    [35] Dong S, Lu Y, Peng G, et al. Furin inhibits epithelial cell injury and alleviates experimental colitis by activating the Nrf2-Gpx4 signaling pathway[J]. Dig Liver Dis, 2021,53(10):1276-1285.
    [36] Lei G, Zhang Y, Hong T, et al. Ferroptosis as a mechanism to mediate p53 function in tumor radiosensitivity[J]. Oncogene, 2021,40(20):3533-3547.
    [37] Wang H, An P, Xie E, et al. Characterization of ferroptosis in murine models of hemochromatosis[J]. Hepatology, 2017,66(2):449-465.
    [38] Cai W, Yang T, Liu H, et al. Peroxisome proliferator-activated receptor gamma (PPARgamma): A master gatekeeper in CNS injury and repair[J]. Prog Neurobiol, 2018,163-164:27-58.
    [39] Bai X, Zheng E, Tong L, et al. Angong Niuhuang Wan inhibit ferroptosis on ischemic and hemorrhagic stroke by activating PPARgamma/AKT/GPX4 pathway[J]. J Ethnopharmacol, 2024,321:117438.
    [40] Duan C, Jiao D, Wang H, et al. Activation of the PPARgamma Prevents Ferroptosis-Induced Neuronal Loss in Response to Intracerebral Hemorrhage Through Synergistic Actions With the Nrf2[J]. Front Pharmacol, 2022,13:869300.
    相似文献
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

复制
分享
文章指标
  • 点击次数:320
  • 下载次数: 0
  • HTML阅读次数: 0
  • 引用次数: 0
历史
  • 收稿日期:2024-02-07
  • 最后修改日期:2024-03-14
  • 录用日期:2024-04-16
您是第9045222 位访问者
版权所有:中国比较医学杂志 主管单位：中国科学技术协会 主办单位：中国实验动物学会 中国医学科学院医学实验动物研究所
地址：北京市朝阳区潘家园南里5号 邮 编 ：100021 电话：010-67779337 E-mail:bjb@cnilas.org
技术支持：北京勤云科技发展有限公司
防诈骗提示！请勿点击不明链接或添加个人微信。编辑部所有邮箱后缀均为@cnilas.org
关闭